Use of Hemadsorption in a Case of Pediatric Toxic Shock Syndrome.
Andrea BerkesEdit SzikszayJános KappelmayerAdrienne KerényiTamás SzabóLászló UjhelyiKrisztina BariGyörgy BallaJózsef BallaPublished in: Case reports in critical care (2017)
The use of extracorporeal blood purification with CytoSorb proved potentially beneficial by removing toxins and inflammatory mediators in this case and could therefore play a role in the clinical management of toxic shock syndrome. Whether CytoSorb has the potential to even positively influence mortality in patients with toxic shock syndrome still needs to be confirmed.